Evidence map›Paper›PMID 32410728›Full record

ArticleeLife2020

Inter-domain dynamics drive cholesterol transport by NPC1 and NPC1L1 proteins.

Piyali Saha, Justin L Shumate, Jenna G Caldwell, Nadia Elghobashi-Meinhardt, Albert Lu, Lichao Zhang, Niclas E Olsson, Joshua E Elias, Suzanne R Pfeffer

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Conformational changes in the Niemann-Pick type C1 protein NCR1 drive sterol translocation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Lysosome-targeted multifunctional lipid probes reveal the sterol transporter NPC1 as a sphingosine interactor.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Piyali SahaDepartment of Biochemistry, Stanford University School of Medicine, Stanford, United States.
Justin L ShumateDepartment of Biochemistry, Stanford University School of Medicine, Stanford, United States.
Jenna G CaldwellDepartment of Biochemistry, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0001-6392-4794
Nadia Elghobashi-MeinhardtDepartment of Chemistry, Technische Universität Berlin, Berlin, Germany.ORCID 0000-0002-1023-6856
Albert LuDepartment of Biochemistry, Stanford University School of Medicine, Stanford, United States.
Lichao ZhangChan Zuckerberg BioHub, Stanford, United States.ORCID 0000-0003-1811-7568
Niclas E OlssonDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0002-9746-0542
Joshua E EliasChan Zuckerberg BioHub, Stanford, United States.
Suzanne R PfefferDepartment of Biochemistry, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0002-6462-984X
Stanford University · USChan Zuckerberg Biohub San Francisco · USTechnische Universität Berlin · DE

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
Cholesterol Regulation of LysosomesR01HL134991 · NHLBI · STANFORD UNIVERSITY · PI PFEFFER, SUZANNE R · 2017 to 2020
$1.6M
NCI NIH HHS P30 CA124435NHLBI NIH HHS R01 HL134991NIH HHS 5R01HL134991-04
6 · The paper itself

Abstract

Transport of LDL-derived cholesterol from lysosomes into the cytoplasm requires NPC1 protein; NPC1L1 mediates uptake of dietary cholesterol. We introduced single disulfide bonds into NPC1 and NPC1L1 to explore the importance of inter-domain dynamics in cholesterol transport. Using a sensitive method to monitor lysosomal cholesterol efflux, we found that NPC1's N-terminal domain need not release from the rest of the protein for efficient cholesterol export. Either introducing single disulfide bonds to constrain lumenal/extracellular domains or shortening a cytoplasmic loop abolishes transport activity by both NPC1 and NPC1L1. The widely prescribed cholesterol uptake inhibitor, ezetimibe, blocks NPC1L1; we show that residues that lie at the interface between NPC1L1's three extracellular domains comprise the drug's binding site. These data support a model in which cholesterol passes through the cores of NPC1/NPC1L1 proteins; concerted movement of various domains is needed for transfer and ezetimibe blocks transport by binding to multiple domains simultaneously.

Indexed as

AnimalsAnticholesteremic AgentsBiological TransportCholesterolEzetimibeHEK293 CellsHeLa CellsHumansIntracellular Signaling Peptides and ProteinsLysosomesMembrane Transport ProteinsMolecular Dynamics SimulationNiemann-Pick C1 ProteinProtein DomainsSf9 CellsStructure-Activity RelationshipAnticholesteremic AgentsCholesterolEzetimibeIntracellular Signaling Peptides and ProteinsMembrane Transport ProteinsNiemann-Pick C1 ProteinNPC1L1 protein, humanNpc1l1 protein, mouseNPC1 protein, humanNpc1 protein, mousebiochemistrycell biologychemical biologycholesterol transportezetimibehumanldl cholesterollysosomeniemann pick c disease

Identifiers

PMID32410728
PMCPMC7228765
OpenAlexW3024366742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.